Targeting FBXO22 enhances radiosensitivity in non-small cell lung cancer by inhibiting the FOXM1/Rad51 axis

Cell Death & Disease, Published online: 31 January 2024; doi:10.1038/s41419-024-06484-1Targeting FBXO22 enhances radiosensitivity in non-small cell lung cancer by inhibiting the FOXM1/Rad51 axis

Source: Cell death and disease - January 31, 2024 Category: Internal Medicine Authors: Yunshang Chen Yun Zhou Xue Feng Zilong Wu Yongqiang Yang Xinrui Rao Rui Zhou Rui Meng Xiaorong Dong Shuangbing Xu Sheng Zhang Gang Wu Xiaohua Jie Source Type: research